new_0222_0554|ITOS|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0554|ITOS|1|ITeos Therapeutics Inc Total Current Assets (Quarterly) (USD)|ITeos Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|ITeos Therapeutics Inc Inventories (Quarterly) (USD)|ITeos Therapeutics Inc Net PP&E (Quarterly) (USD)|ITeos Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|ITeos Therapeutics Inc Total Liabilities (Quarterly) (USD)|ITeos Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|ITeos Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|ITeos Therapeutics Inc Total Deposits (Quarterly) (USD)|ITeos Therapeutics Inc Book Value (Quarterly) (USD)|ITeos Therapeutics Inc Retained Earnings (Quarterly) (USD)|ITeos Therapeutics Inc Treasury Stock (Quarterly) (USD)|ITeos Therapeutics Inc EV to Revenues|ITeos Therapeutics Inc EV to Earnings|ITeos Therapeutics Inc EV to Free Cash Flow|ITeos Therapeutics Inc EV to Assets (Quarterly)|ITeos Therapeutics Inc PS Ratio|ITeos Therapeutics Inc PE Ratio|ITeos Therapeutics Inc Price to Book Value|ITeos Therapeutics Inc PEG Ratio|ITeos Therapeutics Inc Debt to Equity Ratio|ITeos Therapeutics Inc Dividend Yield|ITeos Therapeutics Inc Shareholder Yield (TTM)|ITeos Therapeutics Inc Percent of Shares Outstanding Short|ITeos Therapeutics Inc Total Receivables (Quarterly) (USD)|ITeos Therapeutics Inc Total Payables (Quarterly) (USD)|ITeos Therapeutics Inc Total Capital Stock (Quarterly) (USD)|ITeos Therapeutics Inc Return on Invested Capital|ITeos Therapeutics Inc Quality Ratio Score|ITeos Therapeutics Inc Momentum Score|ITeos Therapeutics Inc Beta (1Y)|ITeos Therapeutics Inc Sustainable Growth Rate (TTM)|ITeos Therapeutics Inc Institutional Investor Ownership Percentage|ITeos Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|ITeos Therapeutics Inc Total Employees (Annual)|ITeos Therapeutics Inc EPS Diluted (Quarterly) (USD)|ITeos Therapeutics Inc Shares Outstanding|ITeos Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|ITeos Therapeutics Inc Ordinary Shares Number (Quarterly)|ITeos Therapeutics Inc Payout Ratio|ITeos Therapeutics Inc Quick Ratio (Quarterly)|ITeos Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|ITeos Therapeutics Inc Stock Buybacks (Quarterly) (USD)|ITeos Therapeutics Inc Effective Tax Rate (TTM)|ITeos Therapeutics Inc Return on Equity|ITeos Therapeutics Inc Net Income (TTM) (USD)|ITeos Therapeutics Inc Revenue (TTM) (USD)|ITeos Therapeutics Inc Dividend Per Share (Quarterly) (USD)|ITeos Therapeutics Inc Revenue (Quarterly) (USD)|ITeos Therapeutics Inc Gross Profit (Quarterly) (USD)|ITeos Therapeutics Inc SG&A Expense (Quarterly) (USD)|ITeos Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|ITeos Therapeutics Inc Net Income (Quarterly) (USD)|ITeos Therapeutics Inc Net Interest Income (Quarterly) (USD)|ITeos Therapeutics Inc Price (USD)|ITeos Therapeutics Inc Total Return Price (USD)|ITeos Therapeutics Inc Enterprise Value (USD)|ITeos Therapeutics Inc 30-Day Average Daily Volume|ITeos Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0554|ITOS|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0554|ITOS|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0554|ITOS|5|91.2857142857|91.2857142857|0|91.2857142857|0|91.2857142857|91.2857142857|91.2857142857|0|91.2857142857|91.2857142857|0|0|0|1.44642857143|0|0|1.44086021505|1.44637681159|0|0|1.44642857143|0|15.25|91.2857142857|91.2857142857|91.2857142857|0|0|30.6|30.6666666667|0|30|91.4|94.4|91.4|35.4285714286|91.4|91.2857142857|0|0|91.4|91.375|0|0|91.2857142857|0|0|0|0|91.4|91.4|91.4|0|1.44642857143|1.44642857143|1.44642857143|1.44903581267|1.42857142857||
new_0222_0554|ITOS|6|7|7|0|7|0|7|7|7|0|7|7|0|0|0|392|0|0|93|345|0|0|392|0|36|7|7|7|0|0|5|6|0|3|10|5|10|14|10|7|0|0|10|8|0|0|7|0|0|0|0|10|10|10|0|392|392|392|363|140||
new_0222_0554|ITOS|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0554|ITOS|201903||||||||||||||||||||||||||||||||||9.9125||-0.5252||0||||-0.5252|||||||||1.769|-4.402|-4.402||||||||
new_0222_0554|ITOS|201906||||||||||||||||||||||||||||||||||9.9125||-0.6836||0||||-0.5806|||||||||2.093|-5.697|-5.755||||||||
new_0222_0554|ITOS|201909||||||||||||||||||||||||||||||||||9.9125||-0.8062||0||||-0.6982|0||||||||2.699|-6.892|-6.921||||||||
new_0222_0554|ITOS|201912|26.076|19.868||1.336||66.832|13.196|53.636||-36.088|-35.865||||||||||||||5.329|1.174|0.001|||||||9.9125||-0.662||0|31.7485|||-0.5423|0|||-22.454|||||2.276|-5.344|-5.376||||||||
new_0222_0554|ITOS|202003|149.271|147.732||1.244||14.518|9.973|4.545||139.452|-41.112||||||||||||||0.233|4.511|0.022|||||||31.7485||-0.2063||-0.332|31.7485|||-0.1653||||-23.299|||||2.418|-5.247|-5.247||||||||
new_0222_0554|ITOS|202006|140.395|136.87||1.251||12.161|7.516|4.645||-47.922|-48.314||||-31.7189|||||||0||5.5244|0.345|2.656|180.973|||||||31.7485|46|-0.3245|31.7485|0|31.7485|||-0.3245||||-24.746|||||2.394|-7.252|-7.202||19.68|19.68|702.0989|||29|
new_0222_0554|ITOS|202009|345.734|339.981||1.287||15.318|10.325|4.993||335.626|-58.994||||-19.5292||||2.5759|||0||2.0521|2.491|2.409|0.035||||||96.4816|24.3492|55|-0.48|35.0448|0|35.0448|||-0.48|-213.66|||-28.505|||||4.799|-10.688|-10.68||24.67|24.67|524.5742|209487.7333||22.77|26.79
new_0222_0554|ITOS|202012|339.544|336.326||1.352||21.361|14.998|6.363||323.197|-73.898||||-33.248||||3.6672|||0||1.7745|0.325|3.026|0.035||||||91.0493|35.0448|62|-0.4253|35.0448|0|35.0448|||-0.4253|0|||-38.033|||||5.729|-14.903|-14.904||33.82|33.82|848.8891|136694.9333||32|41.58
new_0222_0554|ITOS|202103|324.919|321.385||4.396||20.28|11.83|8.45||312.609|-87.432||||-21.4739||||3.8379|||0||3.753|1.241|5.3|0.035|||||||35.0867|68|-0.39|35.101|0|35.101|||-0.39||||-46.32|||||7.046|-13.534|-13.534||34.18|34.18|878.3672|289033.0333||23.51|20.54
new_0222_0554|ITOS|202106|309.768|302.933||5.069||29.187|20.763|8.424||289.498|-113.891||||-12.1016||||3.1142|||0||2.3951|4.232|11.661|0.035|||5|2.4135|||35.12|78|-0.75|35.1481|0|35.1481|||-0.75||||-65.577|||||15.101|-26.459|-26.459||25.65|25.65|598.6158|748493.6333|29.8919|24.03|28.35
new_0222_0554|ITOS|202109|914.137|899.767||4.98||550.34|542.228|8.112||372.039|-44.249||||0.0923|0.0566||91.6139|2.5587||0|0||2.2387|5.43|7.478|0.035|||3|1.1166|||37.4821|74|1.86|35.2575|0|35.2575||1.6694|1.86|0|||14.745|||104.271||8.761|72.413|69.642||27|27|52.1855|169204.1667|9.4447|26.75|35.3
new_0222_0554|ITOS|202112|||||||||||||||1.3135|||157.9831|4.4145|||0||2.0264||||||7|-0.5035||||||||||||||||||||||||46.56|46.56|742.5858|344029.7667|37.67|36.62|35.11